Literature DB >> 26598314

Prevention and control of multi-drug-resistant Gram-negative bacteria: recommendations from a Joint Working Party.

A P R Wilson1, D M Livermore2, J A Otter3, R E Warren4, P Jenks5, D A Enoch6, W Newsholme7, B Oppenheim8, A Leanord9, C McNulty10, G Tanner11, S Bennett12, M Cann13, J Bostock14, E Collins15, S Peckitt16, L Ritchie17, C Fry18, P Hawkey19.   

Abstract

Mesh：

Year:  2015        PMID： 26598314     DOI： 10.1016/j.jhin.2015.08.007

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN： 0195-6701            Impact factor:   3.926


× No keyword cloud information.
  30 in total

1.  The national agenda for Healthcare Associated Infection, Antimicrobial Resistance and Infection Prevention and Control in Scotland: Structures, current priorities and programmes.

Authors:  Jacqui Reilly; Abigail Mullings
Journal:  J Infect Prev       Date:  2017-06-27

2.  Infection control interventions affected by resource shortages: impact on the incidence of bacteremias caused by carbapenem-resistant pathogens.

Authors:  E Kousouli; O Zarkotou; L Politi; K Polimeri; G Vrioni; K Themeli-Digalaki; A Tsakris; S Pournaras
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-09-06       Impact factor: 3.267

3.  Appropriate use of dressings containing nanocrystalline silver to support antimicrobial stewardship in wounds.

Authors:  Emma J Woodmansey; Christopher D Roberts
Journal:  Int Wound J       Date:  2018-08-17       Impact factor: 3.315

Review 4.  Klebsiella pneumoniae in Singapore: Hypervirulent Infections and the Carbapenemase Threat.

Authors:  Ka Lip Chew; Raymond T P Lin; Jeanette W P Teo
Journal:  Front Cell Infect Microbiol       Date:  2017-12-12       Impact factor: 5.293

5.  High burden of Carbapenem-resistant Enterobacteriaceae (CRE) fecal carriage at a teaching hospital: cost-effectiveness of screening in low-resource setting.

Authors:  Abdul Rahman Zaidah; Nurul Izzah Mohammad; Siti Suraiya; Azian Harun
Journal:  Antimicrob Resist Infect Control       Date:  2017-05-02       Impact factor: 4.887

6.  Antibiotic resistance: What is so special about multidrug-resistant Gram-negative bacteria?

Authors:  Martin Exner; Sanjay Bhattacharya; Bärbel Christiansen; Jürgen Gebel; Peter Goroncy-Bermes; Philippe Hartemann; Peter Heeg; Carola Ilschner; Axel Kramer; Elaine Larson; Wolfgang Merkens; Martin Mielke; Peter Oltmanns; Birgit Ross; Manfred Rotter; Ricarda Maria Schmithausen; Hans-Günther Sonntag; Matthias Trautmann
Journal:  GMS Hyg Infect Control       Date:  2017-04-10

7.  The sink as a potential source of transmission of carbapenemase-producing Enterobacteriaceae in the intensive care unit.

Authors:  Deborah De Geyter; Lieve Blommaert; Nicole Verbraeken; Mark Sevenois; Luc Huyghens; Helena Martini; Lieve Covens; Denis Piérard; Ingrid Wybo
Journal:  Antimicrob Resist Infect Control       Date:  2017-02-16       Impact factor: 4.887

8.  Higher third-generation cephalosporin prescription proportion is associated with lower probability of reducing carbapenem use: a nationwide retrospective study.

Authors:  Allison Muller; Xavier Bertrand; Anne-Marie Rogues; Muriel Péfau; Serge Alfandari; Rémy Gauzit; Catherine Dumartin; Houssein Gbaguidi-Haore
Journal:  Antimicrob Resist Infect Control       Date:  2018-01-22       Impact factor: 4.887

9.  Emergence and clonal spread of colistin resistance due to multiple mutational mechanisms in carbapenemase-producing Klebsiella pneumoniae in London.

Authors:  Jonathan A Otter; Michel Doumith; Frances Davies; Siddharth Mookerjee; Eleonora Dyakova; Mark Gilchrist; Eimear T Brannigan; Kathleen Bamford; Tracey Galletly; Hugo Donaldson; David M Aanensen; Matthew J Ellington; Robert Hill; Jane F Turton; Katie L Hopkins; Neil Woodford; Alison Holmes
Journal:  Sci Rep       Date:  2017-10-05       Impact factor: 4.379

10.  Relationship between hospital ward design and healthcare associated infection rates: what does the evidence really tell us? Comment on Stiller et al. 2016.

Authors:  Jennie Wilson; Andrew Dunnett; Heather Loveday
Journal:  Antimicrob Resist Infect Control       Date:  2017-06-26       Impact factor: 4.887
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.